PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAllergic rhinitis seasonal
MeSH D006255 - allergic rhinitis seasonal
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D065631:Allergic rhinitis
$
Success rate
D006255: 
Allergic rhinitis seasonal
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDesloratadine Desloratadine Teva  2011-11-24   
Levocetirizine Levocetirizine  2011-08-22   
PadagisLevocetirizine Levocetirizine  2011-11-07   
Taro PharmaceuticalDesloratadine Desloratadine  2015-06-30   
Levocetirizine Levocetirizine  2013-07-26   
Glenmark PharmaceuticalsLevocetirizine Levocetirizine  2011-02-24   
PerrigoDesloratadine Desloratadine  2011-12-22   
Levocetirizine Levocetirizine  2019-03-28   
GSKFluticasone furoate Alisade  2008-10-06   
Fluticasone furoate Avamys  2008-01-11   
Lupin ResearchDesloratadine Desloratadine  2010-10-25   
Chartwell PharmaceuticalsDesloratadine Desloratadine  2010-12-03   
Levocetirizine Levocetirizine  2017-05-15   
Covis PharmaCiclesonide Alvesco 2028-02-01 2008-01-10   
Ciclesonide Omnaris 2028-02-01 2006-10-20   
Ciclesonide Zetonna 2028-02-01 2012-01-20   
OrganonDesloratadine, Pseudoephedrine Aerinaze  2007-07-30   
Desloratadine Aerius  2001-01-15   
Desloratadine Azomyr  2001-01-15   
Desloratadine, Pseudoephedrine Clarinex  2001-12-21 $134 M Q2/23-Q1/24 
Desloratadine, Pseudoephedrine Clarinex D 2022-03-28 2005-03-03   
Desloratadine Neoclarityn  2001-01-15   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%
8/8
Phase 2
75%
21/28
Phase 3
76%
32/42
Approved: 14Overall Success rate: 57%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use